Login
Navigate Fool.com
Will CARA beat
the market?

CARA THERAPEUTICS (NASDAQ: CARA)

Community Rating: 5 Stars: The Best

13.60 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.53
Previous Close $13.60
Daily Range $13.43 - $13.68
52-Week Range $10.40 - $23.25
Market Cap $307.4M
P/E Ratio -28.08
Dividend (Yield) $0.00 (0.0%)
Volume 79,636
Average Daily Volume 88,184
Current FY EPS -$1.09

How do you think CARA
will perform against the market?

Top CARA Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Why Cara Therapeutics Inc. Shares Jumped

Cara Therapeutics shares soar after providing an update on an early-stage study for its lead compound, CR845. Find out why investors may not want to break out the champagne just yet.

Friday Sector Leaders: Auto Dealerships, Drugs

Sector Update: Healthcare Stock Posting Strong Advance; Cara Therapeutics Jump 17% as Painkiller Tri

Sector Update: Healthcare Stock Posting Strong Advance; Cara Therapeutics Jump 17% as Painkiller Trial Begins

New Stock Coverage: Ruckus Wireless Ready to Make Some Noise

Wall Street ratings agencies set the tone for today's stock market.

Stocks: Insiders Buy at 4 Biotechs -- Dicerna, Ultragenyx, Regulus, and Cara

Regulus Therapeutics renewed its strategic alliance with French pharmaceutical company Sanofi, which added $10 million in equity to its stake in the firm.

US IPO Recap: Ultragenyx doubles and Dicerna triples in home-run week for biotech IPOs

See More CARA News...

Sector

Industry

CARA THERAPEUTICS (CARA) Description

CARA THERAPEUTICS Website: http://www.caratherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks